Victoria L Messerschmidt
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2020First federal award
$1.3MFederal grants as PI2 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
2 awards · $1.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 1, 2023 | NSF | STTR Phase II STTR Phase II:Intravitreal oxygen nanobubble technology for treatment of retinal artery occlusions | $998K | Revive Biotechnology Inc. with University of Illinois at Urbana-Champaign |
| Nov 24, 2020 | NSF | SBIR Phase I SBIR Phase I: Intravitreal oxygen nanobubble technology for treatment of retinal artery occlusions | $256K | Revive Biotechnology Inc. |
Peer ranks
Federal funding#1,850
Awards as PI#1,503
Patents#505
Companies
- Revive Biotechnology Inc.Linked by awards · Medtech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.